News - Mergers & Acquisitions


Current filters:

Mergers & Acquisitions

Popular Filters

201 to 225 of 842 results

Chiesi expands rare disease portfolio with acquisition


Privately-owned Italian drugmaker Chiesi Group has signed, through its UK affiliate, a definitive agreement…

BiotechnologyChiesi FarmaceuticiLamazymMergers & AcquisitionsPharmaceuticalRare diseasesZymenex

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed


US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Stada Arz buys UK OTC manufacturer


German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Fresenius Kabi sets up JV for IV generics in Indonesia


Germany-based Fresenius Kabi, part of the Fresenius Group (FRE: Xetra) has formed a joint venture with…

Asia-PacificFreseniusFresenius KabiGenericsMarkets & MarketingMergers & AcquisitionsSoho Global Health

Pharmstandard agrees key terms for acquiring Singapore drugmaker


Russia's largest pharma company Pharmstandard (PHST RU) - with a market capitalization of around $2 billion…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmstandard

Endo unit to sell anatomical pathology business


USA-based specialty health care company Endo Health Solutions (Nasdaq: ENDP) says that its wholly owned…

BiotechnologyEndo Health SolutionshealthTronicsMergers & AcquisitionsMetamark Genetics

Breckenridge to acquire certain Cypress assets


Privately-held US generic drugmaker Breckenridge Pharmaceutical has entered into an agreement to acquire…

Breckenridge PharmaceuticalsCypress PharmaceuticalsGenericsMergers & AcquisitionsPernix Therapeutics

July a strong month for life sciences IPOs and M&A


The life sciences initial public offering (IPO) market continued to heat up in July as six life sciences…

BiotechnologyCubist PharmaceuticalsFinancialMergers & AcquisitionsPerrigoPharmaceuticalRoche

Luxembourg Haden increases its stake in Bosnia's largest drugmaker


Investment firm Luxembourg Haden, which is reportedly affiliated with the well-known Russian drug distributor…

BosnalijekGenericsImperia PharmaLuxembourg HadenMergers & Acquisitions

PharmAthene and Theraclone agree merger


USA-based biodefense company PharmAthene (NYSE MKT: PIP) and privately-held monoclonal antibody specialist…

BiotechnologyMergers & AcquisitionsPharmAtheneTheraclone Sciences

Actelion to reinforce portfolio with acquisition


Through a US subsidiary, Switzerland-based Actelion (SIX: ATLN), Europe's largest biotech firm, has entered…

ActelionBiotechnologyCeptaris TherapeuticsMergers & AcquisitionsValchlor

New Zealand medicines and vaccines industry bodies merge


Patients in New Zealand could get better access to new and improved vaccines following a merger between…

Mergers & AcquisitionsPharmaceutical

Cubist Pharma signs two acquisition deals in one day


In what must have been a busy day for US drugmaker Cubist Pharmaceuticals (Nasdaq: CBST) announced not…

Antibiotics and Infectious diseasesCubist PharmaceuticalsDificidMergers & AcquisitionsOptimer PharmaceuticalsPharmaceuticaltedizolidTrius Therapeutics

Health care M&A spending grows in 2nd-qtr 2013, says Irving Levin


Health care merger and acquisition activity strengthened in the second quarter of 2013. (View full video:…

BiotechnologyMergers & AcquisitionsPharmaceutical

Acetylon snags $100 million upfront cash and acquisition option


Privately-held Acetylon and US biotech firm Celgene (Nasdaq: CELG) have entered into an exclusive strategic…

Acetylon PharmaceuticalsBiotechnologyCelgeneLicensingMergers & AcquisitionsNeurologicalOncology

Pfizer to separate business into three units: will this lead to spin-outs?


Moving in a direction already advocated by several analysts, US pharma behemoth Pfizer (NYSE: PFE) today…

GenericsManagementMergers & AcquisitionsPfizerPharmaceutical

Elan board agrees $8.6 billion takeover bid


US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp…

ElanGenericsMergers & AcquisitionsPerrigoPharmaceuticalTysabri

Genesis Biopharma completes merger with Lion Biotech


US biotech firm Genesis Biopharma (OTC Bulletin Board: GNBP) says that it has completed a merger with…

BiotechnologyGenesis BiopharmaLion BiotechnologiesMergers & AcquisitionsOncology

Teva and Lonza to discontinue their biosimilars collaboration


Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Recordati acquires Tunisian drugmaker


Italian drugmaker Recordati (RC: MI) has singed announces the signature of the agreements covering the…

GenericsMergers & AcquisitionsOpalia PharmaPharmaceuticalRecordati

Elan posts financials, as it explores sale of the company


Ireland-based Elan Corp (NYSE:ELN) today reported its second quarter 2013 financial results, showing…

ElanFinancialMergers & AcquisitionsPharmaceuticalTysabri

Terms amended in Bellus' acquisition of Thallion


Canada-based drugmaker Bellus Health (TSX: BLU) has amended its agreement to acquire fellow Canadian…

Antibiotics and Infectious diseasesBellus HealthBiotechnologyMergers & AcquisitionsNorth AmericaShigamabsThallion Pharmaceuticals

EU Commission puts conditions on Baxter's acquisition of Gambro


The European Commission has authorized the proposed $4 billion acquisition of privately-held Swedish…

Baxter InternationalGambroMergers & AcquisitionsPharmaceutical

Spectrum Pharma adds to hematology and oncology portfolio with acquisition


US biotech firm Spectrum Pharmaceuticals (Nasdaq: SPPI) says that it has entered into an agreement to…

BiotechnologyMarqiboMenadioneMergers & AcquisitionsSpectrum PharmaceuticalsTalon Therapeutics

201 to 225 of 842 results

Company Spotlight



Back to top